USS Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.7M | Sell |
44,154
-237
| -0.5% | -$106K | 0.12% | 115 |
|
|
2025
Q1 | $21.5M | Sell |
44,391
-12
| -0% | -$5.82K | 0.16% | 97 |
|
|
2024
Q4 | $17.9M | Sell |
44,403
-2,996
| -6% | -$1.21M | 0.12% | 131 |
|
|
2024
Q3 | $22M | Sell |
47,399
-997
| -2% | -$464K | 0.16% | 108 |
|
|
2024
Q2 | $22.7M | Buy |
48,396
+978
| +2% | +$458K | 0.18% | 91 |
|
|
2024
Q1 | $19.8M | Buy |
47,418
+1,449
| +3% | +$606K | 0.16% | 111 |
|
|
2023
Q4 | $18.7M | Sell |
45,969
-6,620
| -13% | -$2.69M | 0.17% | 106 |
|
|
2023
Q3 | $18.3M | Buy |
52,589
+1,087
| +2% | +$378K | 0.2% | 102 |
|
|
2023
Q2 | $18.1M | Buy |
51,502
+563
| +1% | +$198K | 0.21% | 101 |
|
|
2023
Q1 | $16M | Buy |
50,939
+2,625
| +5% | +$827K | 0.22% | 99 |
|
|
2022
Q4 | $13.9M | Hold |
48,314
| – | – | 0.2% | 115 |
|
|
2022
Q3 | $14M | Sell |
48,314
-18,809
| -28% | -$5.45M | 0.2% | 107 |
|
|
2022
Q2 | $18.9M | Sell |
67,123
-3,197
| -5% | -$901K | 0.19% | 112 |
|
|
2022
Q1 | $18.4M | Buy |
70,320
+5,908
| +9% | +$1.54M | 0.15% | 143 |
|
|
2021
Q4 | $14.1M | Hold |
64,412
| – | – | 0.11% | 192 |
|
|
2021
Q3 | $11.7M | Buy |
64,412
+41,375
| +180% | +$7.51M | 0.1% | 210 |
|
|
2021
Q2 | $4.65M | Hold |
23,037
| – | – | 0.04% | 271 |
|
|
2021
Q1 | $4.95M | Hold |
23,037
| – | – | 0.04% | 245 |
|
|
2020
Q4 | $5.44M | Hold |
23,037
| – | – | 0.05% | 219 |
|
|
2020
Q3 | $6.26M | Buy |
23,037
+884
| +4% | +$240K | 0.06% | 183 |
|
|
2020
Q2 | $6.44M | Buy |
+22,153
| New | +$6.44M | 0.07% | 180 |
|